Voyager Therapeutics
(NASDAQ) VYGR
Voyager Therapeutics Financials at a Glance
Market Cap
$238.83M
Revenue (TTM)
$36.49M
Net Income (TTM)
$116.64M
EPS (TTM)
$-2.04
P/E Ratio
-1.94
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Price
$4.04
Volume
639,750
Open
$3.92
Price
$4.04
Volume
639,750
Open
$3.92
Previous Close
$4.05
Daily Range
$3.92 - $4.26
52-Week Range
$2.65 - $5.55
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Price
$4.04
Volume
639,750
Open
$3.92
Previous Close
$4.05
Daily Range
$3.92 - $4.26
52-Week Range
$2.65 - $5.55
VYGR News
VYGR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Voyager Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
141
CEO
Alfred W. Sandrock, Jr., MD
Website
www.voyagertherapeutics.comHeadquarters
Lexington, MA 02139, US
VYGR Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-3%
Net Income Margin
-3%
Return on Equity
-48%
Return on Capital
-48%
Return on Assets
-53%
Earnings Yield
-51.55%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$238.83M
Shares Outstanding
60.31M
Volume
639.75K
Avg. Volume
654.33K
Financials (TTM)
Gross Profit
$40.37M
Operating Income
$131.84M
EBITDA
$127.78M
Operating Cash Flow
$132.47M
Capital Expenditure
$2.60M
Free Cash Flow
$135.06M
Cash & ST Invst.
$196.45M
Total Debt
$36.50M
Voyager Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.59M
-59.9%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$238.83M
N/A
Market Cap/Employee
$1.39M
N/A
Employees
172
N/A
Net Income
$27.94M
+9.9%
EBITDA
$0.00
+100.0%
Quarterly Fundamentals
Net Cash
$106.91M
-44.9%
Accounts Receivable
$1.49M
-29.2%
Inventory
$0.00
N/A
Long Term Debt
$27.20M
-21.3%
Short Term Debt
$7.36M
-0.9%
Return on Assets
-53.18%
N/A
Return on Invested Capital
-48.13%
N/A
Free Cash Flow
$33.43M
+13.3%
Operating Cash Flow
$33.42M
+11.8%